Victoria Christian has held executive leadership roles in clinical and translational research for pharmaceutical, biotechnology, CRO, and academic organizations. Before joining Duke-Margolis, she was COO of the Duke Translational Research Institute (DTRI), a central institutional resource for translational researchers. Christian played an instrumental leadership role in the conceptualization, design, and launch of the Measurement to Understand Re-Classification of Disease of Cabarrus County and Kannapolis (MURDOCK) Study, a major molecular epidemiology initiative made possible by a gift from David H. Murdock. She has held multiple positions at Duke University, where her operational leadership was crucial to the success of large clinical trials.
She has held senior level positions at PAREXEL International and King Pharmaceuticals, and founded NITROX LLC, a Duke spin-out company in 2004.
Ms. Christian has served as Vice President of Duke Medical Strategies, Inc., as Co-Chair for the Duke Medicine Enterprise-Wide Academics Planning Committee, and as Steering or Board member for the Duke Biobank, the Coulter Program, the Stem Cell Research Oversight Committee, and the Biomarker Factory. In January 2016, Victoria was recruited to serve on The Clinical Center Working Group of the NIH Director’s Advisory Board.